News | June 06, 2022
ANI Pharmaceuticals consolidates operation post Novitium acquisition
Operations at Oakville, Canada manufacturing plant expected to end by first quarter 2023
Operations at Oakville, Canada manufacturing plant expected to end by first quarter 2023
Active pharmaceutical ingredients revenue for the quarter was at Rs 913 crore
PharmaLytica Expo to aid in chalking out pharma industry’s $130 Billion growth story by 2030
Susanne Kaestner joins the company as Senior Vice President, Quality and member of the Executive Team, and Dr. Thea Boehm as Vice President, Business Development.
These and many other questions gather worldwide experts of the pharmaceutical industry at the PHARMAP 2022 which takes place in Berlin, Germany on June, 20 - 21, 2022
The partnership between Lockwood and Random42 expands the capabilities and geographic footprint for both organizations.
Follows Zealand Pharma’s appointment of Adam Steensberg as CEO and decision to refocus strategy
Facility features LED lighting, solar panels, automation and innovative temperature-controlled systems to maximize efficiency and minimize environmental impact
GSK to pay $2.1 billion upfront and up to $1.2 billion in potential development milestones
Construction will begin in early 2023, and the plant is scheduled to go onstream in 2025
Subscribe To Our Newsletter & Stay Updated
